Lorena Arranz has been funded 12 million NOK from the FRIPRO program at the Research Council of Norway to gain more insight into early disease development of blood cancers.
Lise Moltzau and colleagues have previously identified several substances that can have a positive impact on blood pressure. In a new study funded by the Novo Nordisk Foundation, they are testing the effectiveness of one of them to treat high blood pressure.
With funding from the SPARK Social Innovation program, Jan Ivar Røssberg and June Ullevoldsæter Lystad, seeks to develop a VR application to be used in the treatment of patients with serious psychotic disorders.
"We must manage the resources from the project in a way that allows us to achieve something even greater in the future," Professor Vessela Kristensen says. She is Principal Investigator and coordinator of the EU project RESCUER.
Professor Kristina Haugaa aims to better understand the heart disease Lamin A/C cardiomyopathy. She has received a grant, together with researchers from the University of Minnesota, for the The LaMinOs project.
With a kick-off conference, the new Centre of Excellence (CoE), CRESCO has officially opened. The new centre aims to gain new and important knowledge about the biological processes in the very first stages of life.
Postdoctoral fellow at the University of Oslo, Youxian Li, receives NOK eight million through the Research Council's program Research project for young talents (FRIPRO). In his project, Li aims to understand how cytotoxic T lymphocytes (CTLs) mediate cell death in cancer.
In his project, Greiff will attempt to understand the rules of antibody-antigen binding, and how this knowledge can be used to develop effective therapeutic antibodies and vaccines.
Harald Stenmark receives the award for his pioneering research in the field of cancer. He has particularly focused on proteins that are central to cell division and to the regulation of the cells' sorting system. Both these processes are critical to understand the cellular events underlying cancer.
Why is there such great variation in the health status of older people? Associate Professor Evandro Fei Fang leads a research collaboration to investigate this question.
Professor Johanna Olweus has been selected for the final of the Cancer Grand Challenges as part of a global research team. If successful, the team hopes to contribute in giving cancer patients new therapies.
Wednesday 21 June was the official opening of the new Centre of Excellence (CoE), PRIMA. The Centre's aim is to develop new and more effective immunotherapy that will improve cancer treatment and cure more patients.
The Norwegian Centre for Mental Disorders Research (NORMENT) has throughout its ten years as a Centre of Excellence (CoE) been a hub for knowledge development and capacity building.
In the EU project PERMANENS, the aim is to develop software that will help clinicians to prevent suicide when working with patients.
Institutional investment in collaboration with South Africa paved the way for new studies on tuberculosis. Anne Margarita Dyrhol-Riise believes that international research collaboration is important and should be stimulated.
Professor Stenmark receives the prestigious award for his pioneering studies of processes in cell membranes, and how misregulation of such processes affects the development of cancer.
Pahnke has been awarded the Oswald Schmiedeberg prize for pharmacology. He receives the prize for his research on, and development of, new drugs for dementia and movement disorders.
Head of Institute Dag Kvale and Deputy Heads of Institute Shuo-Wang Qiao and Torbjørn Omland look forward to lead the institute through a new four-year period.
The new Jebsen centre opened on 1 September and will have a duration of five years. The aim of the centre's research is to improve the prevention and treatment of heart disease. The Centre is led by Professor Torbjørn Omland.
In her new project, FINALphagy, Knævelsrud will study how autophagy is turned off in the body. One of the aims of her research is that it should be applicable in the development of new forms of cancer treatment.
Evandro Fei Fang will lead UiO's contribution to an extensive research project and network, financed through Horizon Europe. The goal is to develop a new medicine using artificial intelligence.
Stenmark receives the award for his groundbreaking research on processes in cell membranes and how misregulation of such processes affects the development of cancer.
The name of the new centre is the K.G. Jebsen Centre for Cardiac Biomarkers. The centre's research will contribute to increased knowledge about cardiac injury and heart failure. It will be led by Professor Torbjørn Omland and be located at the Institute of Clinical Medicine’s campus at Akershus University Hospital.
Therese Sørlie will lead the project in which she will investigate pre-invasive breast cancer stages where the milk ducts are filled with cancer cells, but these have not yet spread into surrounding breast tissue. The grant from the Norwegian Cancer Society is just under 6 million NOK.
Doctoral Research Fellow Christine Rootwelt-Norberg aims to become a leading professional in genetic cardiology. She recently received an award for her presentation at the EuroEcho conference.
.webp?alt=listing)
.jpg?alt=listing)
